The A to Z of Neuroendocrine Cancer

Welcome to my Neuroendocrine Cancer terms and definitions list providing a source of meanings for acronyms and medical terms, all sourced from top Neuroendocrine Cancer sites.

How to use this list:

1. If your term begins with an A, click on A to find all terms beginning with A. Select your term from the list.

2. For numerical terms, please click on the hashtag (#) symbol in the A to Z strip.

3. The term definition including acronym or abbreviation will be given in full along with any of my published articles containing that term as long as I have tagged it on my website to display in the list.

Please note I’m working on the repository throughout 2021 to clean up all definitions, adding and removing links where necessary and ensuring all definitions are linked to at least one article. Where a definition is not yet linked to an article, the definition will still be listed and you will see a message saying “nothing found” and offering you a search of my entire website.

Thanks for supporting this repository.
Ronny

Can’t see the definition you’re looking for? Or is there a broken link? Have a problem with the meaning given? Please contact me using the form below to request an add or update.

In the land of small tumours, there is still a lot of work to do!

I like reading the words of Dr Mark Lewis, an Oncologist and a Neuroendocrine Tumour (NET) patient himself (with MEN1). He always delivers with “enthusiastic vigour”, a term he reduces to “brio” which I then googled! His article as usual sets a scene and he has form for looking back in the history of NETs. I’m […]

The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability

I see a lot of emotional and anxiety issues in my private group. I guess cancer diagnoses are involved in much of it adding to the daily issues faced in the general population. Fears for quality of life, fears of dying, fears for how dependents will manage. For the first few years, I myself thought […]

Q. The best diet for Neuroendocrine Cancer? A. The one that works for you.

Opinion Post I’ve lost count of the number of diet related questions I receive online or are posted in my private Facebook support group. The question is normally worded along these lines: “What should I be eating if I have Neuroendocrine Cancer”. The answer is almost impossible. Here are a few of the reasons why […]

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) – (COMPOSE)

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) – (COMPOSE) is a new trial commencing September 2021. Brief Summary of the COMPOSE trial: This is an Open-label, Multicentre Study. Its purpose is to evaluate the efficacy, safety & patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) […]

New Clinical Trial – Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

When I see a trial for Gastroenteropancreatic NETs (GEPNETs), I know that BP (Bronchopulmonary) NETs (includes Lung) are not included. When you look at the approval wording for the major treatments in use (PRRT Lutathera, Lanreotide), they appear to use the term GEPNETs making BP NETs the poor relative. Clearly there’s highly complex reasons why NETs […]

%d bloggers like this: